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INTRODUCTION
Growth-promoting implants provide considerable improvements in production efficiencies to the beef cattle industry (Folmer et al., 2009; Nichols et al., 2014) . Despite these improvements, the majority of implants only last 60 to 120 d, depending on the dose, before they are no longer effective. Because many cattle require more than 120 d to reach slaughter weight, reimplanting becomes an
The Professional Animal Scientist 32 (2016):53-62; http://dx.doi.org/10.15232/pas.2015-01389 E ffect of increasing initial implant dosage on feedlot performance and carcass characteristics of long-fed steer and heifer calves 54 important management strategy to improve animal efficiency (Preston, 1999) . For instance, cattle implanted with 2 consecutive combination implants containing trenbolone acetate (TBA) and estradiol-17β (E2) have demonstrated a 20.0% increase in ADG and a 13.5% improvement in BW gain efficiency compared with nonimplanted cattle (Duckett and Pratt, 2014) . Implanting strategies use different combinations of implants based on cattle, age, weight, sex, production goals, and estimated days on feed to target gain efficiency, lean meat yield, and carcass quality (Mader, 1997; Reinhardt, 2007; Johnson et al., 2013) . With demand for increased gain efficiency and lean meat yield, usage of greater-dose implants has increased; however, data are limited on the use of these implant combinations in long-fed calves over 170 d. Therefore, the objectives of these experiments were to compare feedlot and carcass performance of long-fed heifers and steers receiving different aggressive initial implant strategies in commercial feedlots.
MATERIALS AND METHODS
The following experiments were conducted in collaborations between Merck Animal Health (De Soto, KS), Cattlemen's Nutrition Service LLC (Lincoln, NE), Bos Terra LP. (Hobson, MT), Innovative Livestock Services Inc. (Great Bend, KS) , and the University of Nebraska-Lincoln. Research was conducted at commercial facilities and followed the guidelines stated in the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching (FASS, 2010) .
Exp. 1
Animals and Treatments. British and British × Continental heifer calves (n = 1,405; 282 ± 3 kg of initial BW) were fed at a commercial feedyard in central Nebraska from Heifers were allotted randomly to pen by arrival block (n = 6) by sorting every 2 heifers into 1 of 3 pens before initial processing. Implant treatments were assigned randomly to pen (n = 1) within a block, for a total of 18 pens. After heifers were randomized into their respective pens, each pen was group weighed on a platform scale before processing to establish pen initial BW. Only products approved by the USDA and United States Food and Drug Administration were administered according to label directions during this study. At processing, heifers received a combination vaccine (Bovi-Shield Gold, Zoetis Inc., Florham Park, NJ) against infectious bovine rhinotracheitis (IBR) virus, bovine virus diarrhea (BVD) virus types 1 and 2, parainfluenza 3 (PI 3 ) virus, and bovine respiratory syncytial virus (BRSV). Additionally, heifers received an oral dose of 10% fenbendazole solution (Safe-Guard, Merck Animal Health) for treatment of internal parasites, an injection of 1% moxidectin (Cydectin, Boehringer Ingelheim/Vetmedica St. Joseph, MO) for treatment of external parasites, and an implant based on the specified treatment assigned. At reimplant (d 90), all pens within a block were brought to the processing facility, reimplanted with Revalor-200, and pen weighed.
Cattle Carcass Evaluation. Slaughter date was determined based on reimplant weight. Prior to shipping for slaughter, heifers from each pen were group weighed on platform scales and shrunk 4% to calculate DP and final live BW. After weighing, heifers were immediately loaded onto trucks and transported 201 km to a commercial abattoir (JBS, Grand Island, NE). Carcass-adjusted final BW was calculated as average HCW divided by the average DP of 65.85% across all animals. Carcass data were collected by personnel from West Texas A&M University (Canyon, TX). Individual HCW were collected at slaughter, and following a 24-h chill, 12th-rib fat thickness, LM area, DP, KPH, marbling scores, percent USDA QG, and percent USDA YG were collected for each pen. Yield grade was calculated using the equation of YG, where YG = 2.50 + (6.35 × 12th-rib fat depth, cm) − (2.06 × LM area, cm 2 ) + (0.2 × KPH, %) + (0.0017 × HCW, kg) (Boggs and Merkel, 1993 Following initial processing, steers were group weighed by pen on a platform scale to establish pen initial BW to be used in performance calculations. Steers were housed in open feedlot pens and had ad libitum access to feed and water. Cattle were adapted to a common finishing diet over a 21-d period, and cattle were fed once daily at approximately 0700 h. The finishing diet contained 61.24% wheat or barley, 20% corn dry distillers grains plus solubles, 7.5% mixed wheat and barley silage, 7.5% alfalfa hay, and 3.76% supplement (DM basis). Diets were common across all pens over the feeding period, and any grain source changes were made to all treatments simultaneously. The supplement was formulated to provide monensin (Rumensin; Elanco Animal Health) at 300 mg per steer daily and tylosin phosphate (Tylan-40; Elanco Animal Health) at 90 mg per steer daily on a DM basis. Steers were fed zilpaterol hydrochloride (Zilmax; Merck Animal Health) at 8.33 mg/ kg of DM for 20 d followed by a 3-d withdrawal before slaughter. Diet samples were obtained monthly from feedbunks and composited for nutrient analysis (Dairy One Labs, Ithaca, NY). Diets provided protein and minerals to meet or exceed NRC (1996) requirements and contained greater than 1.38 Mcal/kg of NEg.
Carcass Evaluation. Slaughter date was determined based on reimplant weight. Steers were weighed by pen on platform scales and shrunk 4% before shipping to determine final shrunk BW. After weighing, steers were immediately loaded on trucks and transported approximately 1,036 km to a commercial abattoir (JBS, Greeley, CO) for slaughter. Carcassadjusted final BW was calculated as HCW divided by a fixed DP of 61.0% across all steers. Carcass measurements were reported by the abattoir based on USDA grades. Individual carcass measurements were collected using the procedures described in Exp. 1.
Exp. 3
Animals and Treatments. Experiment 3 was conducted at a commercial feedlot in central Nebraska from Steers were blocked (n = 3) by arrival date and projected slaughter date based on initial weight. Prior to processing, steers were allocated into 1 of 3 sort pens by sorting every 2 steers in the alley. Sort pens were assigned randomly to 1 of 3 treatments (n = 18; 68 to 95 steers per pen; 6 pens per treatment).
During initial processing, cattle were individually weighed; vaccinated against IBR, BVD (types I and II), PI 3 , and BRSV (Vista 3 SQ; Merck Animal Health); given an oral dose of 10% fenbendazole solution (SafeGuard, Merck Animal Health) for treatment of internal parasites and an injection of 1% moxidectin (Cydectin, Boehringer Ingelheim/Vetmedica) for treatment of external parasites; and individually identified. Following initial processing, steers were group weighed by pen on a platform scale to establish pen initial BW to be used in performance calculations. At time of reimplantation, all cattle within a replication were brought to the processing facility based on a random assignment of processing order and reimplanted with Revalor-200.
Steers were adapted to a common finishing diet over a 23-d transition period consisting of 3 adaptation diets. The finishing diets were the same for each treatment but varied across time because of availability of ingredients. Weighted averages were 49.9% dry-rolled corn (range 41.1-54.6%), 19.2% ADM-Synergy (ADM, Columbus, NE; range 0-28%), and 19.6% wet distillers grains with solubles (range 12-35%). The finishing diet also contained 5% liquid supplement (range 4.1-5.2%), 3.9% mixed hay (range 3.5-4.0%), and 2.4% corn silage (range 0-3%). The supplement was formulated to provide 360 mg per steer daily of monensin (Rumensin; Elanco Animal Health) and 90 mg per steer daily of tylosin phosphate (Tylan; Elanco Animal Health). Because of timing of the trial, at the end of the feeding period, 3 replications were fed zilpaterol hydrochloride (Zilmax; Merck Animal Health) and 3 replications were fed ractopamine hydrochloride (Optaflexx; Elanco Animal Health). Zilpaterol was fed at a rate of 8.33 mg/kg of DM for 20 d followed by a 3-d withdrawal before slaughter. Ractopamine was fed at a rate of 300 mg per steer daily for the last 28 d of the feeding period. Feeding of a β-agonist was equal across treatments and within a replication as all cattle were fed either Zilmax or Optaflexx and therefore not included in the statistical model. Diet samples were obtained monthly from the feedbunks and composited for nutrient analysis (Servi-Tech Laboratories). Diets provided protein and minerals to meet or exceed NRC (1996) requirements and contained greater than 1.45 Mcal/kg of NE g while on the finishing diet.
Carcass Evaluation. Steers were weighed by pen on platform scales and shrunk 4% before shipping to determine final shrunk BW. After weighing, cattle were immediately loaded on trucks and transported approximately 189 km to a commercial abattoir (JBS, Grand Island, NE) for slaughter. Carcass-adjusted final BW was calculated as HCW divided by the DP of 64.5% across all animals. Carcass data were collected by personnel from West Texas A&M University. Individual carcass measurements were the same as described in Exp. 1.
Deads-In and Deads-Out Calculations and Statistical Analysis
Deads-In Calculations. Calculations were made for initial weight by taking the initial pen average (no shrink) divided by the total number of cattle at the start of the trial (Exp. 1, 2, and 3). Final live BW was calculated using the total weight of pen at shipping (shrunk 4%) plus the weight of cattle sold early because of chronic sickness or injury, divided by the number of animals that started the trial (Exp. 1, 2, and 3). Deads-in ADG was calculated from the total kilograms gained (total final weight plus weight of cattle sold early minus total initial weight) divided by total number of animal days (Exp. 1, 2, and 3). Total DMI was calculated by dividing total feed delivered to the pen by the total number of animal days (Exp. 1, 2, and 3). Gain-to-feed ratio was calculated using the deadsin ADG divided by DMI (Exp. 1, 2, and 3).
Deads-Out Calculations. Deadsout initial weight was calculated the same as deads-in (Exp. 1 and 2). Deads-out initial BW was calculated by subtracting individual weight of dead steers or removals from the total initial pen weight, divided by the number of animals slaughtered (Exp. 3). Final live BW was calculated using the total weight of cattle at shipping (shrunk 4%) divided by the total number of cattle shipped excluding deads and cattle sold early (Exp. 1, 2, and 3). Deads-out ADG was determined by dividing the total weight gain (average final weight − average starting weight) by days on feed (Exp. 1, 2, and 3). Deads-out DMI was the same as deads-in, and G:F was calculated using deads-out ADG divided by DMI (Exp. 1, 2, and 3). Carcass-adjusted ADG and G:F were calculated using the same calculations as deads-out ADG and G:F (Exp. 1, 2, and 3).
Statistical Analysis. Live performance and carcass data were analyzed as a randomized complete block design using the Glimmix procedure of SAS (9.2, SAS Institute Inc., Cary, NC). Pen was the experimental unit and the model included the fixed effect of treatment, with block as a random effect (Exp. 1 and 3). The model included replication as a random effect with experimental treatment and weight block as fixed effects (Exp. 2). Treatment averages were calculated using the LSMEANS option of SAS. Treatment differences were significant at an α value equal to or less than 0.05. Frequency data were analyzed using the Glimmix procedure of SAS. The model specified a logistic link function for the binary response, with the number of animals slaughtered identified in the denominator. The means and SE of the proportions for the frequency data were determined using the ILINK option. Treatment differences were significant at an α value equal to or less than 0.05.
RESULTS AND DISCUSSION

Exp. 1-Performance
Deads-out live and carcass-adjusted BW, DMI, and ADG were not different (P ≥ 0.14) between the 3 implant strategies (Table 1) . Carcass-adjusted 2 Initial BW: total pen weight of cattle with no shrink divided by total number of starting heifers (deads-in and deads-out). 3 DMI: calculated from total kilograms delivered to the pen divided by total number of animal days. 4 Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI. 5 Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted performance ADG was calculated the same as live performance using carcass-adjusted final BW. 6 Carcass-adjusted final BW was calculated as average HCW divided by the average DP of 65.85% across all animals. 7 Marbling score: 400 = small 00 , 500 = modest 00 . 8 The numbers represent by treatment the proportion of carcasses within each QG and YG category. In contrast to the current study, Folmer et al. (2009) reported no differences in the YG distribution. Consistent with our observations Hutcheson et al. (2002) reported no differences in gain during the finishing period but a decrease in marbling score as implant dosage was increased. Increasing the dosage of initial implant seems to have little effect on animal gains and feed efficiency; however, the increased dosage could have negative effects on carcass fatness as evidenced by decreased yield and QG. Hutcheson et al. (2002) reported no differences in gain during the finishing period but a decrease in marbling score as implant dosage was increased.
Exp. 2-Performance
While previous studies have used Rev-XS as a single implant strategy for steers fed for 131 to 243 d on feed (Parr et al., 2011; Nichols et al., 2014) , there is little information available on using Rev-XS in combination with other implants to maximize production efficiency.
Cattle from different implanting strategies did not differ (P ≥ 0.11) in live or carcass-adjusted final BW; however, cattle that received Revalor-XS as an initial implant numerically had heavier live and carcass-adjusted final BW (Table 2) . Intake was not different (P = 0.38) across implant strategy. Although not statistically different (P ≥ 0.13), steers that received Rev-XS/IS, Rev-XS/S, and Rev-XS/200 had numerically greater deads-in and deads-out live or carcass-adjusted ADG compared with Rev-IS/200. Efficiency of gain was not different (P ≥ 0.32) among implant strategy on a live or carcass-adjusted basis. Parr et al. (2011) reported no differences in live and carcass-adjusted final BW, DMI, ADG, and G:F for cattle implanted with Rev-IS followed by Rev-S at reimplant compared with a single implant of Rev-XS at d 131, 174, and 243 on feed. Similarly, Nichols et al. (2014) reported no differences in feedlot gain and efficiency after 157 d on feed when cattle were implanted with Rev-IS followed by Rev-S at reimplant compared with a single Rev-XS. Parr et al. (2011) reported an increase in carcass-adjusted final BW and ADG when using a single Rev-XS implant for 197 d compared with a Rev-IS/S implant program and suggested that this could be due to decreased concentrations of TBA and E2 before reimplanting (d 90 to 103), which caused a decrease in overall gain. Samber et al. (1996) evaluated different implant strategies using multiple implants with similar overall concentrations of TBA and E2 as those used in the current study, noting no differences in final BW, DMI, ADG, and G:F between the treatments.
In Exp. 2, HCW, DP, 12th-rib fat thickness, and marbling scores were not different (P ≥ 0.18) among implant treatments. Nichols et al. (2014) reported no differences in HCW, 12th-rib fat thickness, or marbling score when comparing Rev-XS with Rev-IS/S. Similarly, Parr et al. (2011) reported no differences in HCW, DP, and 12th-rib fat thickness between implant programs in cattle fed for 174 or 243 d. Contrary to the current study, Samber et al. (1996) reported that cattle implanted 3 times with Rev-S compared with 2 times with Rev-S had less 12th-rib fat thickness.
Longissimus muscle area was largest (P < 0.01) for Rev-XS/200 implant programs, with Rev-XS/IS and Rev-XS/S treatments being intermediate and Rev-IS/200 having the smallest LM area. Samber et al. (1996) also reported that increasing the amount of TBA and E2 used in the implant program increased LM area but had no effect on HCW or DP.
In Exp. 2, QG distributions were not different (P ≥ 0.19) by implant treatment. No significant differences (P ≥ 0.07) were observed between 2 Initial BW: total pen weight of cattle with no shrink divided by total number of starting steers (deads-in and deads-out). 3 DMI: calculated from total kilograms delivered to the pen divided by total number of animal days. 4 Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI. 5 Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted performance ADG were calculated the same as live performance using carcass-adjusted final BW. 6 Carcass-adjusted final BW was calculated as HCW divided by the average DP of 61.0% across all steers. 7 One replication was slaughtered early and no data were collected, so carcass characteristics were analyzed with only 7 replications. 8 Marbling score: 400 = small 00 , 500 = modest 00 . 9 The numbers represent by treatment the proportion of carcasses within each QG and YG category. 2 Initial BW: total pen weight of cattle with no shrink subtracting individual weights of dead or removed animals divided by the number of remaining animals (deads-out). 3 DMI: calculated from total kilograms delivered to the pen divided by total number of animal days. 4 Deads-in performance: ADG was calculated from total kilograms gained (total final weight subtracting total starting weight with deads and removed included) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI. 5 Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted performance ADG were calculated the same as live performance using carcass-adjusted final BW. 6 Carcass-adjusted final BW was calculated as HCW divided by the DP of 64.5% across all animals. 7 Marbling score: 400 = small 00 , 500 = modest 00 . 8 The numbers represent by treatment the proportion of carcasses within each QG and YG category. 
Exp. 3-Performance
There were no differences (P ≥ 0.36) in live or carcass-adjusted cattle performance among the 3 implant strategies (Table 3) . As in Exp. 2, final live and carcass-adjusted BW did not differ (P ≥ 0.64) among implant programs. Similarly, deads-out carcass-adjusted ADG and G:F were not different (P ≥ 0.36) between implant strategy, agreeing with observations from Exp. 2. These results are consistent with Samber et al. (1996) and Nichols et al. (2014) , who reported no differences in DMI, ADG, G:F, and final BW between implant strategies of increased TBA and E2 dose. Additionally, there were no differences (P ≥ 0.15) in HCW or USDA marbling score when comparing the 3 treatments (Table 3) Samber et al. (1996) reported no differences in HCW between aggressive implant strategies but noted a decrease in 12th-rib fat thickness and calculated YG as implant dosage increased. There were no differences (P ≥ 0.28) in the percentage of cattle that graded Choice or greater; however, the Rev-200/200 and Rev-XS/200 treatments had an increase (P = 0.03) in the percentage of carcasses that graded USDA Select compared with Rev-IS/200. Samber et al. (1996) reported that there was a decrease in the percentage of Choice and Prime grading carcasses as implant dosage was increased. Similarly, Nichols et al. (2014) reported no differences in QG distribution between steers implanted with Rev-IS/S or Rev-XS. Differences in carcass characteristics between Exp. 2 and 3 could be due to differences in reimplant date, cattle weight, BW, and cattle handling at reimplant in addition to environmental factors as similar differences between implant strategies were noted by Parr et al. (2011) and Nichols et al. (2014) .
Animal Health
Morbidity differences (P < 0.05) were detected with Rev-IH/200 having the least, Rev-200/200 being intermediate, and Rev-H/200 having the greatest (P = 0.05) percentage of morbidity (Table 4) . However, there were no differences (P ≥ 0.12) in mortality or rejected-percentage. Rev-XS/200 had the lowest morbidity percentage, and Rev-XS/S had the greatest (P = 0.02). However, as noted in Exp. 1, there were no differences (P ≥ 0.26) in the mortality or rejected-percentage. In Exp. 3 there were no differences (P ≥ 0.60) in the number of animals treated for illness, mortalities, or removed animals. Munson et al. (2012) reported that there were numerical differences in steer morbidity and no differences in steer mortality when comparing an initial to a delayed implant treatment similar to a lesser-and greater-dose initial implant, which is in agreement with the current steer studies. Additionally, Gruber et al. (2011) reported no differences in morbidity between implant treatments in both steers and heifers. Whereas differences in morbidity in Exp. 1 and 2 were detected and not in Exp. 3, these data would suggest that increased initial implant dosage does not have an effect on animal health.
IMPLICATIONS
Economic incentives have led to use of more aggressive implant strategies to illicit a greater gain and efficiency response. However, it appears the use of aggressive implant strategies and increased dosages may not be beneficial for daily gain and efficiency of gain during the finishing phase in steers and heifers. Use of aggressive implant strategies could decrease carcass fatness and improve YG but reduce QG in heifer and steer calves when compared with a traditional implant strategy that uses a lesser-dose initial implant followed by a greaterdose terminal implant.
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